Skip to content

Opening book details…

Can I read Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis on EtoBox?

Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis by Huaqiang Ouyang; Weidong Ma; Xiangli Jiang; Anna Sandström Gerdtsson; Donglin Liu; Zhanyu Pan is a Medicine article available to read on EtoBox.

What is Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis about?

Background: For advanced pancreatic cancer, pulmonary metastases (PM) have been considered favorable factors compared to metastases of other sites, but it remains unknown whether the prognosis of patients with synchronous liver and lung metastases is better than that of non-PM. Methods: Data was derived from a two-decade cohort and included 932 cases of pancreatic adenocarcinoma with synchronous liver metastases (PACLM). Propensity score matching (PSM) was applied to balance 360 selected cases, grouped into PM (n = 90) and non-PM (n = 270). Overall survival (OS) and survival-related factors were analyzed. Results: In PSM-adjusted data, the median OS was 7.3 and 5.8 months, for PM and non-PM, respectively (p = 0.16). Multivariate analysis revealed that male gender, poor performance status, higher hepatic tumor burden, ascites, elevated carbohydrate antigen 19-9, and lactate dehydrogenase were factors of poor survival (p < 0.05). Chemotherapy was the only independent significant factor of favorable prognosis (p < 0.05). Conclusion: Although lung involvement was indicated to be a favorable prognostic factor for patients with PACLM in the whole cohort, PM were not associated with bette

Who reads Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?—A propensity score analysis?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Huaqiang Ouyang; Weidong Ma; Xiangli Jiang; Anna Sandström Gerdtsson; Donglin Liu; Zhanyu Pan
Publisher
Informa UK Limited
Published
2023
Language
EN
Field
Medicine (Health Sciences)

More by Huaqiang Ouyang; Weidong Ma; Xiangli Jiang; Anna Sandström Gerdtsson; Donglin Liu; Zhanyu Pan

Browse all works by Huaqiang Ouyang; Weidong Ma; Xiangli Jiang; Anna Sandström Gerdtsson; Donglin Liu; Zhanyu Pan